Clinical TrialsSearch results
Number of results: 237
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase I/II study of percutaneous vertebroplasty (JIVROSG-0202)
- Malignant vertebral bone tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)
- osteoid osteoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)
- Symptomatic metastatic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)
- Symptomatic intrapelvic malignant tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0203)
- Unresectable malignant lung tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A Phase 3, open-label, crossover study to evaluate self-administration of rozanolixizumab by study participants with generalized Myasthenia Gravis(gMG).
- Generalized Myasthenia Gravis
- Kaori Ikeda
- 2023-06-13
Completed
- A Phase 3 study of Efgartigimod PH20 SC in patient with Generalized Myasthenia Gravis
- Generalized Myasthenia Gravis (gMG)
- Matsuura Yuji
- 2021-07-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01